<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02894073</url>
  </required_header>
  <id_info>
    <org_study_id>PI2015_843_0010</org_study_id>
    <nct_id>NCT02894073</nct_id>
  </id_info>
  <brief_title>Interest of a Skin Transilluminator (Such as the VeinViewer速Vision Device) for Peripheral Venous Catheter Placement in the Obese Patient</brief_title>
  <acronym>VEINVIEW</acronym>
  <official_title>Interest of a Skin Transilluminator (Such as the VeinViewer速Vision Device) for Peripheral Venous Catheter Placement in the Obese Patient: a Randomized, Controlled Pilot Study</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Centre Hospitalier Universitaire, Amiens</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Centre Hospitalier Universitaire, Amiens</source>
  <brief_summary>
    <textblock>
      Placement of a peripheral venous catheter (PVC) is the most common invasive procedure in
      anaesthesia and perhaps even in the field of medicine as a whole. This procedure may be
      challenging in the obese patient - even for the most experienced healthcare professionals.

      In a study, PVC placement was considered to be difficult in 46% of obese patients but only
      13% of non-obese patients.

      Placement of a central venous catheter is an option when PVC placement is impossible,
      although central access is associated with a non-negligible risk of complications
      (pneumothorax, infection, arterial puncture, etc.).

      Facilitating peripheral venous access in obese patients should shorten the time required for
      PVC placement, decrease the number of perfusion attempts (a source of dissatisfaction and
      discomfort for the patients) and limit the use of a central venous catheter.

      Although a number of novel vein visualisation devices (such as the VeinViewer速Vision from
      Christie Medical) have been developed to guide PVC placement, there are no literature data on
      the value of these devices in the management of difficult venous access in obese patients.
    </textblock>
  </brief_summary>
  <overall_status>Not yet recruiting</overall_status>
  <start_date>September 2016</start_date>
  <completion_date type="Anticipated">September 2017</completion_date>
  <primary_completion_date type="Anticipated">September 2017</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>duration of the PVC placement procedure</measure>
    <time_frame>Day 0</time_frame>
    <description>the time between the first puncture and the confirmation of successful PVC placement via the injection of physiological saline</description>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">60</enrollment>
  <condition>General Surgery</condition>
  <arm_group>
    <arm_group_label>control group</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
    <description>PVC placement performed in the usual manner: visual inspection of the patient's anatomy</description>
  </arm_group>
  <arm_group>
    <arm_group_label>visualisation group</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>a skin transilluminator (such as the VeinViewer速Vision) is used to guide PVC placement</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>skin transilluminator</intervention_name>
    <description>VeinViewer</description>
    <arm_group_label>visualisation group</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  All obese adult patients scheduled for surgery.

          -  Social security coverage

        Exclusion Criteria:

          -  Age &lt;18.

          -  Contra-indication to PVC placement.

          -  Legal guardianship.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Youssef ALAMI CHENTOUFI, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>CHU Amiens</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Youssef ALAMI CHENTOUFI, MD</last_name>
    <phone>+33 3 22 08 79 67</phone>
    <email>alami.youssef@chu-amiens.fr</email>
  </overall_contact>
  <location>
    <facility>
      <name>CHU Amiens</name>
      <address>
        <city>Amiens</city>
        <zip>80054</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Youssef ALAMI CHENTOUFI, MD</last_name>
      <phone>+33 3 22 08 79 67</phone>
      <email>alami.youssef@chu-amiens.fr</email>
    </contact>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>September 2016</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>September 5, 2016</study_first_submitted>
  <study_first_submitted_qc>September 5, 2016</study_first_submitted_qc>
  <study_first_posted type="Estimate">September 9, 2016</study_first_posted>
  <last_update_submitted>September 5, 2016</last_update_submitted>
  <last_update_submitted_qc>September 5, 2016</last_update_submitted_qc>
  <last_update_posted type="Estimate">September 9, 2016</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>obese patients</keyword>
  <keyword>peripheral venous catheter</keyword>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

